Search Results - N. Yu. Velts

Refine Results
  1. 1
    Methodological Approaches to Risk Management of Advanced Therapy Medicinal Products

    Methodological Approaches to Risk Management of Advanced Therapy Medicinal Products by A. A. Taube, N. Yu. Velts

    Published 2023-09-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Ototoxicity of Aminoglycosides the Modern Concepts

    Ototoxicity of Aminoglycosides the Modern Concepts by E. V. Shubnikova, N. Yu. Velts

    Published 2023-02-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers

    Analysis of Noncompliances with Legislative Requirements in Pharmacovigilance Materials of Registration Dossiers by E. O. Zhuravleva, N. Yu. Velts, G. V. Kutekhova

    Published 2021-12-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier

    Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier by I. I. Snegireva, E. O. Zhuravleva, N. Yu. Velts

    Published 2020-12-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review)

    Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review) by N. Yu. Velts, O. V. Velts, R. N. Alyautdin

    Published 2024-07-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Nonsteroidal anti-inflammatory drugs: problems of safe use

    Nonsteroidal anti-inflammatory drugs: problems of safe use by N. Yu. Velts, E. O. Zhuravleva, T. M. Bukatina, G. V. Kutekhova

    Published 2018-03-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Limits for the Content of Heavy Metals and Arsenic as a Means of Ensuring Safe Use of Herbal Medicinal Products

    Limits for the Content of Heavy Metals and Arsenic as a Means of Ensuring Safe Use of Herbal Medicinal Products by M. S. Galenko, I. V. Gravel, N. Yu. Velts, R. N. Alyautdin

    Published 2021-07-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors

    Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors by N. Yu. Velts, E. O. Zhuravleva, G. V. Kutekhova, N. V. Tereshkina

    Published 2024-10-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice

    Pharmacovigilance System Master File: An Overview of Changes in the EAEU Good Pharmacovigilance Practice by N. Yu. Velts, E. O. Zhuravleva, G. V. Kutekhova, N. V. Tereshkina

    Published 2023-03-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Rules of good laboratory practice: analysis of changes in the legislation

    Rules of good laboratory practice: analysis of changes in the legislation by N. Yu. Velts, T. M. Bukatina, E. Yu. Pasternak, T. N. Nikolaeva, S. V. Romanova

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    The rules of good laboratory practice

    The rules of good laboratory practice by N. Yu. Velts, R. N. Alyautdin, A. S. Kazakov, T. M. Bukatina, M. A. Darmostukova

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Comparative Analysis of International Databases of Adverse Drug Reactions

    Comparative Analysis of International Databases of Adverse Drug Reactions by A. S. Kazakov, M. A. Darmostukova, T. M. Bukatina, N. Yu. Velts, R. N. Alyautdin

    Published 2020-09-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Safety of apremilast: risk of psychical disorders

    Safety of apremilast: risk of psychical disorders by T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. Yu. Pasternak, T. V. Romanova

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Malaria and safety issues associated with antimalarial drugs

    Malaria and safety issues associated with antimalarial drugs by A. S. Kazakov, T. M. Bukatina, N. Yu. Velts, M. A. Darmostukova, E. O. Zhuravleva

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    The risk management system as the important part of good pharmacovigilance practices (GVP)

    The risk management system as the important part of good pharmacovigilance practices (GVP) by A. S. Kazakov, K. E. Zatolochina, B. K. Romanov, T. M. Bukatina, N. Yu. Velts

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents

    Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents by E. V. Shubnikova, T. M. Bukatina, N. Yu. Velts, D. A. Kaperko, G. V. Kutekhova

    Published 2020-03-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Vaccine Safety International Monitoring

    Vaccine Safety International Monitoring by M. A. Darmostukova, I. I. Snegireva, N. Yu. Velts, A. S. Kazakov, R. N. Alyautdin

    Published 2019-03-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    Drug-induced liver injuries in pregnancy in the context of polypragmasy

    Drug-induced liver injuries in pregnancy in the context of polypragmasy by N. Yu. Velts, E. O. Zhuravleva, M. A. Darmostukova, K. E. Zatolochina, O. S. Alyautdina

    Published 2018-02-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Drug Safety Monitoring Information

    Drug Safety Monitoring Information by E. V. Shubnikova, E. O. Zhuravleva, N. Yu. Velts, P. M. Giulakhmedova, A. A. Druzhinina

    Published 2021-07-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE

    SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE by E. O. Zhuravleva, N. Yu. Velts, G. V. Kutekhova, M. A. Darmostukova, R. N. Alyautdin

    Published 2018-06-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: